Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR

.bubble-images, .bubble-images img { border-radius: 50%; }

Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR

How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into the venture philanthropy approach of EB Research Partnership, the largest global nonprofit organization dedicated to treating and curing Epidermolysis Bullosa (EB). To date, EB Research Partnership has funded 80 research projects, which has led to 30 clinical trials, including 3 Phase III trials. View video of the conference call on our website.


Read the Summary


Moderator

Kristin Schneeman
Program Director, FasterCures

 

Panel Experts and Speakers

Michael Hund
CEO of EB Research Partnership

 

Alex Silver
Chairman of EB Research Partnership

 

Daniel de Boer
CEO of ProQR Therapeutics
 

 

Mark de Souza
CEO of Wings Therapeutics